Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ipsen
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
A histologically confirmed, locally advanced or metastatic prostate cancer, and naïve to androgen deprivation therapy, and a candidate for hormonal treatment.
An estimated survival time of at least twelve months according to the investigator's assessment.
A performance status score ≤ 2 according to the World Health Organisation (WHO) criteria.
You may not be if
Previous surgical castration.
Previous or has planned curative prostate cancer therapy (radiation/surgery)
Previous hormone therapy (GnRH analogues, estrogens or anti-androgens)
Patients with risk of a serious complication in the case of tumour flare (vertebral metastases threatening spinal cord compression or significant obstructive uropathy)
